OptimizeRx to Participate at the 33rd Annual Virtual ROTH Conference on March 15-17, 2021GlobeNewsWire • 03/03/21
OptimizeRx Corp. (OPRX) Soars 12%: Is Further Upside Left in the Stock?Zacks Investment Research • 03/02/21
OptimizeRx Corporation (OPRX) CEO William Febbo on Q4 2020 Results - Earnings Call TranscriptSeeking Alpha • 02/25/21
OptimizeRx Corp. (OPRX) Q4 Earnings and Revenues Surpass EstimatesZacks Investment Research • 02/24/21
OptimizeRx Reports Q4 2020 Revenue Up 123% to Record $16.4 Million, Driving Net Income of $1.4 Million or $0.08 Per ShareGlobeNewsWire • 02/24/21
OptimizeRx Sets Fourth Quarter and Full Year 2020 Conference Call for Wednesday, February 24, 2021 at 4:30 p.m. ETGlobeNewsWire • 02/18/21
OptimizeRx to Present at the SVB Leerink 10th Annual Global Healthcare Conference on February 25, 2021GlobeNewsWire • 02/16/21
OptimizeRx Expects Q4 2020 Revenue up 117% to Record $16 Million, Full Year up 75% to Record $43 MillionGlobeNewsWire • 01/25/21
OptimizeRx to Present at the B. Riley Securities 2021 Vision Day Virtual Conference on January 28, 2021GlobeNewsWire • 01/21/21
OptimizeRx to Present at the H.C. Wainwright Virtual BioConnect Conference on January 11, 2021GlobeNewsWire • 01/06/21
OptimizeRx's TelaRep™ Recognized as One of the Most Innovative Products for Life Sciences by PM360GlobeNewsWire • 12/11/20
OptimizeRx CEO, William Febbo, to Speak at Bank of America 4th Annual HCIT and Digital Health Symposium Today, December 9, 2020GlobeNewsWire • 12/09/20
OptimizeRx Partners with Komodo Health to Expand Life Sciences Support at Point-of-CareGlobeNewsWire • 12/07/20
OptimizeRx Launches AI-Powered Real-World Evidence Solution on Its Point-of-Care PlatformGlobeNewsWire • 12/01/20
OptimizeRx Ranked Number 432 Fastest-Growing Company in North America on Deloitte's 2020 Technology Fast 500™GlobeNewsWire • 11/18/20
OptimizeRx and Questex's Fierce Life Sciences Tackle Industry's Top Challenges in Design Thinking Event, Innovate4OutcomesGlobeNewsWire • 11/17/20